Gastric Electric Stimulator Market

Gastric Electric Stimulator Market Forecast and Outlook 2025 to 2035

The global gastric electric stimulator market is projected to grow from USD 315.4 million in 2025 to approximately USD 489.8 million by 2035, recording an absolute increase of USD 175.4 million over the forecast period. This translates into a total growth of 55.6%, with the market forecast to expand at a CAGR of 4.5% between 2025 and 2035.

The overall market size is expected to grow by nearly 1.6 times during the same period, supported by increasing demand for advanced gastric treatment solutions, rising adoption of implantable medical devices, and growing focus on minimally invasive therapeutic approaches across global healthcare and medical device sectors.

Quick Stats for Gastric Electric Stimulator Market

• Gastric Electric Stimulator Market Value (2025): USD 315.4 million
• Gastric Electric Stimulator Market Forecast Value (2035): USD 489.8 million
• Gastric Electric Stimulator Market Forecast CAGR: 4.5%
• Leading Product Type in Gastric Electric Stimulator Market: Implantable Gastric Stimulators (77.2%)
• Key Growth Regions in Gastric Electric Stimulator Market: Asia Pacific, North America, and Europe
• Top Players in Gastric Electric Stimulator Market: Medtronic, IntraPace, ReShape Lifesciences, EnteroMedics, Allergan, LivaNova, Johnson & Johnson, Obalon Therapeutics

Between 2025 and 2030, the market is projected to expand from USD 315.4 million to USD 388.2 million, resulting in a value increase of USD 72.8 million, which represents 41.5% of the total forecast growth for the decade. This phase of development will be shaped by rising demand for gastric treatment technologies, increasing applications in gastroparesis management optimization, and growing penetration in emerging medical markets. Healthcare manufacturers are expanding their gastric stimulator production capabilities to address the growing demand for specialized treatment systems in various therapeutic applications and medical processes.

Gastric Electric Stimulator Market Key Takeaways

Metric	Value
Estimated Value in (2025E)	USD 315.4 million
Forecast Value in (2035F)	USD 490.8 million
Forecast CAGR (2025 to 2035)	4.5%

From 2030 to 2035, the market is forecast to grow from USD 388.2 million to USD 490.8 million, adding another USD 102.6 million, which constitutes 58.5% of the overall ten-year expansion. This period is expected to be characterized by the expansion of advanced medical device manufacturing facilities, the integration of sophisticated gastric stimulation technologies, and the development of customized treatment systems for specific therapeutic applications. The growing adoption of medical device standards and treatment efficacy requirements will drive demand for ultra-high efficiency gastric electric stimulator systems with enhanced performance specifications and consistent therapeutic characteristics.

Between 2020 and 2025, the market experienced steady expansion, driven by increasing recognition of gastric treatment technologies' importance in medical device operations and growing acceptance of specialized stimulation solutions in complex therapeutic processes. The market developed as healthcare providers recognized the need for high-efficiency stimulation systems to address stringent regulatory requirements and improve overall treatment outcomes. Research and development activities have begun to emphasize the importance of advanced gastric stimulation technologies in achieving better efficacy and quality in therapeutic processes.

Why is the Gastric Electric Stimulator Market Growing?

Market expansion is being supported by the increasing demand for advanced therapeutic solutions and the corresponding need for high-efficiency stimulation systems in gastric applications across global healthcare and medical device operations. Modern medical providers are increasingly focused on specialized gastric stimulation technologies that can improve treatment efficacy, reduce complications, and enhance patient outcomes while meeting stringent regulatory requirements. The proven efficacy of gastric electric stimulator services in various therapeutic applications makes them an essential component of comprehensive treatment strategies and medical device production.

The growing focus on healthcare industry transformation and advanced treatment optimization is driving demand for ultra-efficient gastric electric stimulator systems that meet stringent performance specifications and regulatory requirements for medical applications. Healthcare manufacturers' preference for reliable, high-performance stimulation systems that can ensure consistent treatment outcomes is creating opportunities for innovative gastric stimulation technologies and customized therapeutic solutions. The rising influence of regulatory guidelines and treatment protocols is also contributing to increased adoption of premium-grade gastric electric stimulator systems across different medical applications and therapeutic systems requiring specialized stimulation technology.

Opportunity Pathways - Gastric Electric Stimulator Market

The gastric electric stimulator market represents a specialized growth opportunity, expanding from USD 315.4 million in 2025 to USD 490.8 million by 2035 at a 4.5% CAGR. As healthcare providers prioritize treatment efficacy, regulatory compliance, and patient outcomes in complex therapeutic processes, gastric electric stimulator systems have evolved from a niche medical technology to an essential component enabling effective treatment, therapy optimization, and multi-stage medical production across healthcare operations and specialized therapeutic applications.

The convergence of medical technology expansion, increasing treatment automation adoption, specialized healthcare organization growth, and regulatory requirements creates momentum in demand. High-efficiency formulations offering superior stimulation performance, cost-effective implantable systems balancing performance with economics, and specialized external variants for critical applications will capture market premiums, while geographic expansion into high-growth Asian healthcare markets and emerging market penetration will drive volume leadership. Regulatory focus on treatment quality and therapeutic reliability provides structural support.

• Pathway A - Implantable Gastric Stimulators Dominance: Leading with 77.2% market share, implantable gastric stimulators drive primary demand through complex therapeutic workflows requiring specialized stimulation systems for gastric treatment. Advanced formulations enabling improved therapeutic efficacy, reduced complication risks, and enhanced patient outcomes command premium pricing from healthcare providers requiring stringent performance specifications and regulatory compliance. Expected revenue pool: USD 270.0-330.0 million.
• Pathway B - Gastroparesis Market Leadership: Dominating with 63.5% market share through optimal balance of performance and clinical effectiveness, gastroparesis serves most therapeutic applications while meeting treatment requirements. This application addresses both efficacy standards and operational considerations, making it the preferred choice for healthcare operations and therapeutic processes seeking reliable performance. Opportunity: USD 230.0-280.0 million.
• Pathway C - Asian Market Acceleration: India (6.0% CAGR) and China (5.3% CAGR) lead global growth through healthcare infrastructure expansion, treatment capability development, and domestic gastric electric stimulator demand. Strategic partnerships with local manufacturers, regulatory compliance expertise, and supply chain localization enable expansion of medical technology in major healthcare hubs. Geographic expansion upside: USD 100.0-140.0 million.
• Pathway D - Hospitals Premium Segment: Hospitals serve specialized applications requiring exceptional performance specifications for critical therapeutic processes. Hospital formulations supporting complex treatment requirements, advanced medical applications, and performance-sensitive processes command significant premiums from advanced healthcare companies and specialized medical organizations. Revenue potential: USD 220.0-290.0 million.
• Pathway E - Advanced Technology & Integration Systems: Companies investing in sophisticated gastric stimulation technologies, medical device systems, and automated treatment processes gain competitive advantages through consistent system performance and therapeutic quality reliability. Advanced manufacturing capabilities enabling customized specifications and rapid scale-up capture premium healthcare partnerships. Technology premium: USD 120.0-170.0 million.
• Pathway F - Supply Chain Optimization & Reliability: Specialized distribution networks, strategic inventory management, and reliable supply chain systems create competitive differentiation in healthcare markets requiring consistent gastric stimulator availability. Companies offering guaranteed supply security, technical support, and regulatory documentation gain preferred supplier status with compliance-focused healthcare providers. Supply chain value: USD 80.0-120.0 million.
• Pathway G - Emerging Applications & Market Development: Beyond traditional gastroparesis, gastric electric stimulation in obesity, functional dyspepsia, and specialized treatment systems represent growth opportunities. Companies developing new applications, supporting R&D initiatives, and expanding into adjacent medical markets capture incremental demand while diversifying revenue streams. Emerging opportunity: USD 60.0-90.0 million.

Segmental Analysis

The market is segmented by product type, application, end user, and region. By product type, the market is divided into implantable gastric stimulators and external stimulators. Based on application, the market is categorized into gastroparesis, obesity, and others. By end user, the market is divided into hospitals, specialty clinics, and others. Regionally, the market is classified into Asia Pacific, North America, Europe, Latin America, Middle East & Africa.

By Product Type, Implantable Gastric Stimulators Segment Accounts for 77.2% Market Share

The implantable gastric stimulators segment is projected to account for 77.2% of the market in 2025, reaffirming its position as the category's dominant product type. Healthcare manufacturers increasingly recognize the optimal balance of performance and therapeutic effectiveness offered by implantable gastric stimulators for most medical applications, particularly in chronic condition treatment and therapeutic processes. This product type addresses both performance requirements and clinical considerations while providing reliable stimulation across diverse therapeutic applications.

This product type forms the foundation of most treatment protocols for gastric stimulation applications, as it represents the most widely accepted and clinically viable level of gastric stimulation technology in the industry. Performance control standards and extensive clinical testing continue to strengthen confidence in implantable stimulator formulations among healthcare and medical device providers. With increasing recognition of the cost-performance optimization requirements in therapeutic treatment, implantable gastric stimulator systems align with both operational efficiency and treatment quality goals, making them the central growth driver of comprehensive therapeutic strategies.

By Application, Gastroparesis Segment Accounts for 63.5% Market Share

Gastroparesis is projected to represent 63.5% of gastric electric stimulator demand in 2025, underscoring its role as the primary application segment driving market adoption and growth. Healthcare manufacturers recognize that gastroparesis treatment requirements, including complex therapeutic processes, specialized stimulation needs, and multi-stage treatment systems, often require specialized stimulator services that standard therapeutic technologies cannot adequately provide. Gastric electric stimulators offer enhanced treatment efficacy and regulatory compliance in gastroparesis applications.

The segment is supported by the growing nature of gastroparesis diagnosis, requiring sophisticated stimulation systems, and the increasing recognition that specialized gastric stimulation technologies can improve therapeutic performance and treatment outcomes. The healthcare providers are increasingly adopting evidence-based treatment guidelines that recommend specific gastric stimulation services for optimal therapeutic outcomes. As understanding of gastroparesis complexity advances and regulatory requirements become more stringent, gastric electric stimulators will continue to play a crucial role in comprehensive treatment strategies within the gastroparesis market.

By End User, Hospitals Segment Accounts for 64.6% Market Share

Hospitals are projected to represent 64.6% of gastric electric stimulator demand in 2025, establishing their position as the leading end user segment in the market. Hospital facilities increasingly require sophisticated gastric stimulation solutions to manage complex patient cases and provide comprehensive treatment services across diverse therapeutic portfolios. The segment benefits from the growing complexity of gastric disorder treatment requirements and the need for reliable stimulation strategies in high-volume hospital operations.

The hospital segment is characterized by stringent quality control requirements, regulatory compliance demands, and the need for consistent therapeutic performance across multiple treatment platforms. These facilities prioritize gastric stimulation solutions that can integrate seamlessly with existing hospital workflows while providing reliable performance across various therapeutic applications. The segment's growth is supported by increasing hospital consolidation, expanding treatment capabilities, and rising demand for specialized gastric treatment services that require advanced stimulation capabilities.

What are the Drivers, Restraints, and Key Trends of the Gastric Electric Stimulator Market?

The gastric electric stimulator market is advancing steadily due to increasing recognition of gastric treatment technologies' importance and growing demand for high-efficiency stimulation systems across the healthcare and medical device sectors. The market faces challenges, including complex implantation processes, potential for device compatibility variations during implementation and maintenance, and concerns about supply chain consistency for specialized medical equipment. Innovation in gastric stimulation technologies and customized therapeutic protocols continues to influence product development and market expansion patterns.

Expansion of Advanced Medical Technologies and Treatment Automation

The growing adoption of advanced medical device manufacturing facilities is enabling the development of more sophisticated gastric electric stimulator production and performance control systems that can meet stringent regulatory requirements. Specialized medical systems offer comprehensive gastric stimulation services, including advanced therapeutic processes and treatment systems that are particularly important for achieving high-efficacy requirements in medical applications. Advanced medical channels provide access to premium services that can optimize therapeutic performance and reduce treatment complications while maintaining cost-effectiveness for large-scale medical operations.

Integration of Digital Medical Systems and Patient Management Systems

Modern healthcare companies are incorporating digital technologies such as real-time performance monitoring, automated medical systems, and supply chain integration to enhance gastric electric stimulator manufacturing and distribution processes. These technologies improve service performance, enable continuous therapeutic monitoring, and provide better coordination between manufacturers and customers throughout the supply chain. Advanced digital platforms also enable customized performance specifications and early identification of potential service deviations or supply disruptions, supporting reliable therapeutic treatment production.

Analysis of the Gastric Electric Stimulator Market by Key Country

Country	CAGR (2025-2035)
India	6.0%
China	5.3%
Brazil	4.6%
USA	4.0%
South Korea	3.6%
Germany	3.1%
Japan	2.9%

The market is experiencing varied growth globally, with India leading at a 6.0% CAGR through 2035, driven by the expansion of healthcare infrastructure development, increasing gastric treatment capabilities, and growing domestic demand for high-efficiency stimulation systems. China follows at 5.3%, supported by medical technology expansion, growing recognition of specialized gastric stimulation technology importance, and expanding manufacturing capacity. Brazil shows growth at 4.6%, emphasizing advanced medical technologies and precision therapeutic applications. USA records 4.0% growth, with a focus on developing medical technology and healthcare industries. South Korea shows 3.6% growth, representing a mature market with established treatment patterns and regulatory frameworks. Germany exhibits 3.1% growth, supported by advanced manufacturing frameworks and comprehensive medical guidelines. Japan demonstrates 2.9% growth, emphasizing healthcare infrastructure expansion and systematic therapeutic approaches.

India Demonstrates Growing Market Potential with Healthcare Infrastructure Development

India is projected to exhibit robust growth with a CAGR of 6.0% through 2035, driven by ongoing healthcare expansion and increasing recognition of high-efficiency gastric stimulation systems as essential therapeutic components for complex treatment processes. The country's expanding healthcare infrastructure and growing availability of specialized gastric stimulation capabilities are creating significant opportunities for gastric electric stimulator adoption across both domestic and export-oriented medical facilities. Major international and domestic healthcare companies are establishing comprehensive production and distribution networks to serve the growing population of medical providers and therapeutic manufacturers requiring high-performance gastric stimulation systems across clinical and research applications throughout India's major healthcare hubs.

The Indian government's strategic focus on healthcare modernization and therapeutic advancement is driving substantial investments in specialized gastric stimulation capabilities. This policy support, combined with the country's large domestic healthcare market and expanding treatment requirements, creates a favorable environment for the gastric electric stimulator market development. Indian manufacturers are increasingly focusing on high-value medical technologies to improve therapeutic capabilities, with gastric electric stimulators representing a key component in this healthcare transformation.

• Government initiatives supporting healthcare development and therapeutic modernization are driving demand for high-efficiency gastric stimulation systems throughout major medical and biotechnology centers, including Mumbai, Delhi, and Bangalore regions.
• Manufacturing capacity expansion and gastric stimulation system development are supporting appropriate utilization of gastric electric stimulators among medical providers and therapeutic manufacturers nationwide, with particular growth in hospital operations and specialty clinic services.

China Demonstrates Exceptional Market Potential with Medical Technology Growth

China is expanding at a CAGR of 5.3%, supported by increasing medical technology accessibility, growing healthcare awareness, and developing technology market presence across the country's major medical manufacturing clusters. The country's large healthcare sector and increasing recognition of specialized gastric stimulation systems are driving demand for effective high-efficiency stimulation solutions in both therapeutic development and medical applications. International healthcare companies and domestic manufacturers are establishing comprehensive distribution channels to serve the growing demand for quality gastric stimulation systems while supporting the country's position as an emerging medical technology market.

China's healthcare sector continues to benefit from favorable medical policies, expanding manufacturing capabilities, and cost-competitive healthcare infrastructure development. The country's focus on becoming a global medical technology hub is driving investments in specialized gastric stimulation technology and therapeutic infrastructure. This development is particularly important for gastric electric stimulator applications, as medical providers seek reliable domestic sources for critical gastric stimulation technologies to reduce import dependency and improve supply chain security.

• Rising awareness about advanced gastric stimulation options and improving manufacturing capabilities are creating opportunities for specialized stimulation systems across medical and healthcare settings in major hubs like Beijing, Shanghai, and Guangzhou.
• Growing manufacturing infrastructure development and technology adoption are supporting increased access to high-efficiency gastric electric stimulators among companies requiring comprehensive stimulation capabilities, particularly in medical technology and healthcare organizations.

Brazil Shows Strong Latin American Leadership

Brazil's market expansion benefits from diverse healthcare demand, including medical device modernization in São Paulo and Rio de Janeiro, gastric stimulation development programs, and government healthcare programs that increasingly incorporate gastric electric stimulator solutions for therapeutic enhancement applications. The country maintains a 4.6% CAGR through 2035, driven by rising healthcare awareness and increasing adoption of gastric stimulation benefits, including superior therapeutic capabilities and reduced treatment complexity.

Market dynamics focus on cost-effective gastric electric stimulator solutions that balance advanced stimulation features with affordability considerations important to Brazilian healthcare operators. Growing medical infrastructure creates demand for modern gastric stimulation systems in new therapeutic facilities and medical equipment modernization projects.

Strategic Market Considerations:

• Medical and therapeutic segments leading growth with focus on gastric stimulation enhancement and operational efficiency applications
• Regional healthcare requirements are driving a diverse product portfolio from basic gastric electric stimulator systems to advanced therapeutic platforms
• Import dependency challenges offset by potential local development partnerships with international gastric stimulation manufacturers
• Government healthcare initiatives beginning to influence procurement standards and treatment requirements

USA Maintains Technology Leadership

The USA's advanced medical technology market demonstrates sophisticated therapeutic deployment with documented gastric stimulation effectiveness in healthcare facility departments and medical centers through integration with existing therapeutic systems and stimulation infrastructure. The country leverages manufacturing expertise in medical technology and therapeutic systems integration to maintain a 4.0% CAGR through 2035. Healthcare centers, including major metropolitan areas, showcase premium installations where gastric electric stimulator systems integrate with comprehensive medical information systems and therapeutic platforms to optimize treatment accuracy and operational workflow effectiveness.

American medical technology providers prioritize system reliability and regulatory compliance in gastric stimulation development, creating demand for premium systems with advanced features, including quality validation and integration with US healthcare standards. The market benefits from established healthcare industry infrastructure and a willingness to invest in advanced gastric stimulation technologies that provide long-term operational benefits and compliance with medical regulations.

South Korea Demonstrates Advanced Technology Integration

South Korea's market emphasizes advanced gastric electric stimulator features, including precision therapeutic processing and integration with comprehensive medical information systems that manage treatment scheduling, quality monitoring, and operational support applications through unified healthcare platforms. The country is projected to show a 3.6% CAGR through 2035, driven by healthcare modernization under medical equipment upgrades and advanced healthcare technology support for gastric stimulation systems. Korean medical operators prioritize operational effectiveness with gastric electric stimulators, delivering consistent therapeutic assistance through advanced stimulation algorithms and operational compliance capabilities.

Technology deployment channels include major healthcare technology contractors, specialized gastric stimulation suppliers, and healthcare authority programs that support professional installation for complex therapeutic applications. Medical platform integration capabilities with established healthcare systems expand market appeal across diverse gastric stimulation requirements seeking operational efficiency and healthcare compliance benefits.

Performance Metrics:

• Medical systems in Seoul, Busan, and Incheon are leading gastric electric stimulator adoption for specialized therapeutic applications
• Healthcare technology contractor channels maintaining 68% market share for complex medical integration applications
• Healthcare authority programs support 32% of gastric electric stimulator acquisitions across therapeutic and clinical facility segments
• Medical platform compatibility with major healthcare information systems, driving procurement selection criteria

Germany Shows Strong Regional Leadership

Germany's market expansion benefits from diverse healthcare demand, including therapeutic modernization in Berlin and Munich, gastric stimulation development programs, and government healthcare programs that increasingly incorporate gastric electric stimulator solutions for treatment enhancement applications. The country maintains a 3.1% CAGR through 2035, driven by rising healthcare awareness and increasing adoption of gastric stimulation benefits, including superior therapeutic capabilities and reduced treatment complexity.

Market dynamics focus on cost-effective gastric electric stimulator solutions that balance advanced stimulation features with affordability considerations important to German medical operators. Growing healthcare infrastructure creates demand for modern gastric stimulation systems in new therapeutic facilities and medical equipment modernization projects.

Strategic Market Considerations:

• Therapeutic and medical segments leading growth with focus on gastric stimulation enhancement and operational efficiency applications
• Regional healthcare requirements are driving a diverse product portfolio from basic gastric electric stimulator systems to advanced medical platforms
• Import dependency challenges offset by potential local development partnerships with international gastric stimulation manufacturers
• Government healthcare initiatives beginning to influence procurement standards and therapeutic requirements

Japan Emphasizes Precision and Integration Excellence

Japan demonstrates steady market development with a 2.9% CAGR through 2035, distinguished by healthcare operators' preference for high-quality gastric electric stimulator systems that integrate seamlessly with existing medical equipment and provide reliable long-term operation in specialized therapeutic applications. The market prioritizes advanced features, including precision stimulation algorithms, quality validation, and integration with comprehensive medical platforms that reflect Japanese healthcare expectations for technological sophistication and operational excellence.

Japanese medical technology providers focus on system reliability and precision in gastric electric stimulator development, creating demand for premium systems with advanced features including automated quality monitoring and comprehensive therapeutic support. The market benefits from established healthcare research infrastructure and investment in gastric stimulation technology that provides long-term therapeutic benefits.

Strategic Market Indicators:

• Premium focus on precision systems with advanced stimulation algorithms and high-reliability capabilities
• Integration requirements with existing medical information systems and therapeutic management platforms
• Focus on gastric electric stimulator reliability and long-term performance in clinical applications

Europe Market Split by Country

The gastric electric stimulator market in Europe is projected to grow from USD 73.0 million in 2025 to USD 113.5 million by 2035, registering a CAGR of 4.5% over the forecast period. Germany is expected to maintain its leadership position with a 23.8% market share in 2025, rising to 24.2% by 2035, supported by its advanced healthcare manufacturing infrastructure, precision therapeutic capabilities, and strong medical presence throughout major biotechnology regions.

The United Kingdom follows with a 15.3% share in 2025, projected to reach 15.6% by 2035, driven by advanced medical protocols, healthcare innovation integration, and expanding specialty therapeutic networks serving both domestic and international markets. France holds a 15.1% share in 2025, expected to increase to 15.4% by 2035, supported by healthcare infrastructure expansion and growing adoption of high-efficiency gastric stimulation systems. Italy commands a 12.6% share in 2025, projected to reach 12.9% by 2035, while Spain accounts for 9.9% in 2025, expected to reach 10.1% by 2035. The Rest of Europe region, including Nordic countries, Eastern Europe, and smaller Western European markets, is anticipated to hold 23.3% in 2025, declining slightly to 21.8% by 2035, attributed to market consolidation toward larger core markets with established healthcare and therapeutic capabilities.

Competitive Landscape of the Gastric Electric Stimulator Market

The market is characterized by competition among established healthcare manufacturers, specialty medical device companies, and therapeutic suppliers focused on delivering high-efficiency, consistent, and reliable gastric stimulation systems. Companies are investing in stimulation technology advancement, performance control enhancement, strategic partnerships, and customer technical support to deliver effective, efficient, and reliable gastric electric stimulator solutions that meet stringent healthcare and therapeutic requirements. Gastric stimulation optimization, performance validation protocols, and supply chain strategies are central to strengthening product portfolios and market presence.

Medtronic leads the market with comprehensive high-efficiency gastric stimulation system offerings with a focus on performance consistency and therapeutic reliability for medical applications. IntraPace provides specialized gastric electric stimulator systems with focus on gastroparesis applications and comprehensive technical support services. ReShape Lifesciences focuses on advanced gastric stimulation technologies and customized therapeutic solutions for stimulation systems serving global markets. EnteroMedics delivers established medical systems with strong performance control systems and customer service capabilities.

Allergan operates with a focus on bringing innovative gastric stimulation technologies to specialized medical applications and emerging markets. LivaNova provides comprehensive gastric stimulation system portfolios, including gastric electric stimulators, across multiple therapeutic applications and treatment processes. Johnson & Johnson specializes in customized gastric stimulation solutions and performance management systems for medical systems with focus on regulatory compliance. Obalon Therapeutics provides reliable supply chain solutions and technical expertise to enhance market accessibility and customer access to essential gastric stimulation systems.

Key Players in the Gastric Electric Stimulator Market

• Medtronic
• IntraPace
• ReShape Lifesciences
• EnteroMedics
• Allergan (AbbVie)
• LivaNova
• Johnson & Johnson (Ethicon)
• Obalon Therapeutics
• Neurogastrx
• GI Dynamics
• EndoStim
• BaroNova
• Fractyl Health
• Vibrant Gastro
• Abilitech

Scope of the Report

Items	Values
Quantitative Units (2025)	USD 315.4 million
Product Type	Implantable Gastric Stimulators, External Stimulators
Application	Gastroparesis, Obesity, Others
End User	Hospitals, Specialty Clinics, Others
Regions Covered	Asia Pacific, North America, Europe, Latin America, Middle East & Africa
Countries Covered	India, China, Brazil, USA, South Korea, Germany, Japan and 40+ countries
Key Companies Profiled	Medtronic, IntraPace, ReShape Lifesciences, EnteroMedics, Allergan, LivaNova, Johnson & Johnson, and Obalon Therapeutics
Additional Attributes	Dollar sales by product type and application, regional demand trends, competitive landscape, manufacturer preferences for specific gastric stimulation systems, integration with specialty medical supply chains, innovations in gastric stimulation technologies, performance monitoring, and therapeutic optimization

Gastric Electric Stimulator Market by Segments

• Product Type:

  • Implantable Gastric Stimulators
  • External Stimulators

• Application:

  • Gastroparesis
  • Obesity
  • Others

• End User:

  • Hospitals
  • Specialty Clinics
  • Others

• Region:

  • Asia Pacific

    • China
    • India
    • Japan
    • South Korea
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia Pacific

  • North America

    • United States
    • Canada
    • Mexico

  • Europe

    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Nordic
    • BENELUX
    • Rest of Europe

  • Latin America

    • Brazil
    • Argentina
    • Chile
    • Rest of Latin America

  • Middle East & Africa

    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkey
    • South Africa
    • Other African Countries
    • Rest of Middle East & Africa